Finally available in Canada, the first epinephrine nasal spray certainly meets a public need, but will have to prove its worth to last, according to three experts interviewed by Profession Santé.
INESSS is updating its national medical protocol and group prescription template for medication adjustment and monitoring in adults with primary hypertension, and releasing a new guide for clinicians.
A Health Canada safety review examines the potential risk of hepatotoxicity with oral ashwagandha products following international concerns about a possible association.
Study examines the association between initiation of GLP-1 RAs versus dipeptidyl peptidase-4 inhibitors and fragility fracture risk in adults with type 2 diabetes.
